“eptinezumab” Archives

in
Entry Author Date Location
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Teva’s Approved Migraine Drug Fails Again to Blunt Rarer Headache 04/23/19 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen’s 09/14/18 National
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines 05/17/18 National
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Alder BioPharma’s Schatzman Steps Down as CEO by “Mutual Decision” 03/20/18 Seattle
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
Alder Plans for FDA Filing After Migraine Drug Posts Strong Results 01/08/18 Seattle
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Alder Drug Cuts Down Migraines in Study, But Still Trails Rivals 06/27/17 Seattle
Page 1 of 1